Amino Acid Transporter ATB0,+ as a delivery system for drugs and prodrugs.
about
SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer.Immunohistochemical and functional characterization of peptide, organic cation, neutral and basic amino acid, and monocarboxylate drug transporters in human ocular tissues.Expression Profile of Cationic Amino Acid Transporters in Rats with Endotoxin-Induced Uveitis.Transcorneal permeation of L- and D-aspartate ester prodrugs of acyclovir: delineation of passive diffusion versus transporter involvement.Functional and molecular analysis of D-serine transport in retinal Müller cellsRecent perspectives in ocular drug delivery.Strategies for therapy of retinal diseases using systemic drug delivery: relevance of transporters at the blood-retinal barrier.Targeted prodrugs in oral drug delivery: the modern molecular biopharmaceutical approach.Membrane transporters for the special amino acid glutamine: structure/function relationships and relevance to human health.Glutamine transporters in mammalian cells and their functions in physiology and cancer.Imaging tumour ATB0,+ transport activity by PET with the cationic amino acid O-2((2-[18F]fluoroethyl)methyl-amino)ethyltyrosine.Molecular expression and functional activity of efflux and influx transporters in hypoxia induced retinal pigment epithelial cellsDifferential expression of folate receptor-alpha, sodium-dependent multivitamin transporter, and amino acid transporter (B (0, +)) in human retinoblastoma (Y-79) and retinal pigment epithelial (ARPE-19) cell lines.Transcriptomic and Immunohistochemical Profiling of SLC6A14 in Pancreatic Ductal Adenocarcinoma.Transporter targeted gatifloxacin prodrugs: synthesis, permeability, and topical ocular delivery.Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer.Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types.Modern prodrug design for targeted oral drug delivery.Methionyl-Methionine Promotes α-s1 Casein Synthesis in Bovine Mammary Gland Explants by Enhancing Intracellular Substrate Availability and Activating JAK2-STAT5 and mTOR-Mediated Signaling Pathways.
P2860
Q35213098-1F928E8D-A78D-4BD5-8372-14714E1127FBQ36573373-E5C8A58D-845F-47B6-9A3F-40643B0B95E0Q37054059-EA91A163-23E1-44B4-99FC-5AE0FEEB99F6Q37147862-73B3D693-69D0-439F-8497-A911D2DF220FQ37172871-30179961-8C4B-4A62-8A91-56991AEFF343Q37256549-5BF7E47C-952A-4E7D-9F42-BC6274ED1F4BQ37950461-10FF5898-BA07-4B97-B35E-2A9C02DB588BQ38019048-12C8ABA0-A731-43DC-8C8F-97051BBBD909Q38243334-590CDB1B-A8F4-40DA-A63E-C82740DF7353Q38685207-84BA0C0C-2AC9-4163-93CE-BA4F5F00384DQ39048536-B09F501C-D5C7-483D-A607-B90BCC53C5DAQ39130285-341CBB94-715A-47F0-B291-65F6445E58B6Q39401864-0FA97CCF-87D6-4AB6-9D94-1ADA33EBDBF7Q41645489-431B889C-F143-4F99-BD90-8270DA85CFA3Q41841013-6D65D261-DC71-41AF-A4F5-2D244E8E7F60Q47128109-66C36A75-0D8F-4CF1-B221-B0A0BD8A3C2FQ49472868-2A829C63-2237-4A19-8824-211AD76E740BQ51042522-A2A0CAD4-FFD3-46F1-AAD3-735AA63F891AQ54263463-88EBA46C-91AA-4DF4-BBA9-DA65720EAB7A
P2860
Amino Acid Transporter ATB0,+ as a delivery system for drugs and prodrugs.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Amino Acid Transporter ATB0,+ as a delivery system for drugs and prodrugs.
@ast
Amino Acid Transporter ATB0,+ as a delivery system for drugs and prodrugs.
@en
type
label
Amino Acid Transporter ATB0,+ as a delivery system for drugs and prodrugs.
@ast
Amino Acid Transporter ATB0,+ as a delivery system for drugs and prodrugs.
@en
prefLabel
Amino Acid Transporter ATB0,+ as a delivery system for drugs and prodrugs.
@ast
Amino Acid Transporter ATB0,+ as a delivery system for drugs and prodrugs.
@en
P1476
Amino Acid Transporter ATB0,+ as a delivery system for drugs and prodrugs.
@en
P2093
M E Ganapathy
V Ganapathy
P304
P356
10.2174/156800805774912953
P577
2005-12-01T00:00:00Z